ATE201591T1 - Vorbeugung und behandlung von topischen viralen infektionen mit perfluoropolyäthern oder deren zusammensetzungen - Google Patents

Vorbeugung und behandlung von topischen viralen infektionen mit perfluoropolyäthern oder deren zusammensetzungen

Info

Publication number
ATE201591T1
ATE201591T1 AT96111163T AT96111163T ATE201591T1 AT E201591 T1 ATE201591 T1 AT E201591T1 AT 96111163 T AT96111163 T AT 96111163T AT 96111163 T AT96111163 T AT 96111163T AT E201591 T1 ATE201591 T1 AT E201591T1
Authority
AT
Austria
Prior art keywords
perfluoropolyethers
prevention
compositions
treatment
viral infections
Prior art date
Application number
AT96111163T
Other languages
English (en)
Inventor
Morris A Mann
Giovanni Pantini
Original Assignee
Morris A Mann
Ausimont Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT96MI001070 external-priority patent/IT1282748B1/it
Application filed by Morris A Mann, Ausimont Spa filed Critical Morris A Mann
Application granted granted Critical
Publication of ATE201591T1 publication Critical patent/ATE201591T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Polyethers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96111163T 1995-08-22 1996-07-11 Vorbeugung und behandlung von topischen viralen infektionen mit perfluoropolyäthern oder deren zusammensetzungen ATE201591T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US266595P 1995-08-22 1995-08-22
IT96MI001070 IT1282748B1 (it) 1996-05-28 1996-05-28 Prevenzione e trattamento delle infezioni virali topiche con perfluoropolieteri o loro composizioni.

Publications (1)

Publication Number Publication Date
ATE201591T1 true ATE201591T1 (de) 2001-06-15

Family

ID=26331394

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96111163T ATE201591T1 (de) 1995-08-22 1996-07-11 Vorbeugung und behandlung von topischen viralen infektionen mit perfluoropolyäthern oder deren zusammensetzungen

Country Status (10)

Country Link
US (1) US5719194A (de)
EP (1) EP0759301B1 (de)
JP (1) JPH09136838A (de)
KR (1) KR100420260B1 (de)
AT (1) ATE201591T1 (de)
AU (1) AU706952B2 (de)
CA (1) CA2183804A1 (de)
DE (1) DE69613058T2 (de)
MX (1) MX9603596A (de)
TW (1) TW415844B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN030794A0 (en) 1994-12-22 1995-01-27 Aruba International Pty Ltd Discontinuous plasma or serum delipidation
US7439052B2 (en) * 2000-06-29 2008-10-21 Lipid Sciences Method of making modified immunodeficiency virus particles
AUPQ846900A0 (en) * 2000-06-29 2000-07-27 Aruba International Pty Ltd A vaccine
US7407663B2 (en) * 2000-06-29 2008-08-05 Lipid Sciences, Inc. Modified immunodeficiency virus particles
US20090017069A1 (en) * 2000-06-29 2009-01-15 Lipid Sciences, Inc. SARS Vaccine Compositions and Methods of Making and Using Them
US7407662B2 (en) * 2000-06-29 2008-08-05 Lipid Sciences, Inc. Modified viral particles with immunogenic properties and reduced lipid content
US20060060520A1 (en) * 2001-06-25 2006-03-23 Bomberger David C Systems and methods using a solvent for the removal of lipids from fluids
EP1409108A4 (de) * 2001-06-25 2007-11-14 Lipid Sciences Inc Hohlfaserberührungssysteme zur entfernung von lipiden aus fluiden
US6991727B2 (en) * 2001-06-25 2006-01-31 Lipid Sciences, Inc. Hollow fiber contactor systems for removal of lipids from fluids
US7033500B2 (en) * 2001-06-25 2006-04-25 Lipid Sciences, Inc. Systems and methods using multiple solvents for the removal of lipids from fluids
EP1412045A4 (de) * 2001-06-25 2007-05-02 Lipid Sciences Inc Ein lösungsmittel zur entfernung von lipiden aus fluiden verwendende systeme und verfahren
US20040106556A1 (en) * 2002-08-26 2004-06-03 Yanhong Zhu Method of treating and preventing alzheimer disease through administration of delipidated protein and lipoprotein particles
CA2531227A1 (en) * 2003-07-03 2005-02-10 Lipid Sciences Inc. Methods and apparatus for creating particle derivatives of hdl with reduced lipid content
US7393826B2 (en) 2003-07-03 2008-07-01 Lipid Sciences, Inc. Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
US6960803B2 (en) * 2003-10-23 2005-11-01 Silicon Storage Technology, Inc. Landing pad for use as a contact to a conductive spacer
DE112010000922B4 (de) * 2009-02-27 2021-08-05 Ntn Corporation Schmierfettzusammensetzung, fettgeschmiertes lager, verwendung des fettgeschmierten lagers, und gelenkkupplung für kardanwelle
RU2673342C2 (ru) 2013-02-19 2018-11-26 Джонсон энд Джонсон Консьюмер Инк. Способы и композиции для улучшения внешнего вида и формирования рубцовой ткани
CA3083194A1 (en) 2017-11-22 2019-05-31 Hdl Therapeutics, Inc. Systems and methods for priming fluid circuits of a plasma processing system
AU2018396009A1 (en) 2017-12-28 2020-07-16 Hdl Therapeutics, Inc. Methods for preserving and administering pre-beta high density lipoprotein extracted from human plasma
RU2697887C1 (ru) * 2018-08-06 2019-08-21 Федеральное государственное бюджетное учреждение науки Тихоокеанский институт биоорганической химии им. Г.Б. Елякова Дальневосточного отделения Российской академии наук (ТИБОХ ДВО РАН) Средство, обладающее противовирусным действием в отношении вирусов клещевого энцефалита и герпеса простого I типа
RU2697886C1 (ru) * 2018-08-06 2019-08-21 Федеральное государственное бюджетное учреждение науки Тихоокеанский институт биоорганической химии им. Г.Б. Елякова Дальневосточного отделения Российской академии наук (ТИБОХ ДВО РАН) Противовирусная композиция

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3897502A (en) * 1971-10-22 1975-07-29 Airco Inc Process for making fluorinated ethers
IT1183530B (it) * 1985-03-29 1987-10-22 Monteluos S P A Composizioni per cosmesi comprendente perfluoropolieteri
IL82308A (en) * 1986-06-26 1990-11-29 Ausimont Spa Microemulsions containing perfluoropolyethers
IT1229222B (it) * 1989-03-31 1991-07-26 Ausimont Srl Emulsioni stabili di perfluoropolieteri
IT1244032B (it) * 1990-12-18 1994-06-28 Ausimont Spa Emulsioni stabili di perfluoropolieteri e sostanze grasse e processo per la loro preparazione

Also Published As

Publication number Publication date
AU6218996A (en) 1997-03-13
DE69613058D1 (de) 2001-07-05
EP0759301A3 (de) 1997-10-01
CA2183804A1 (en) 1997-02-23
MX9603596A (es) 1997-06-28
DE69613058T2 (de) 2002-03-07
EP0759301B1 (de) 2001-05-30
US5719194A (en) 1998-02-17
KR970009797A (ko) 1997-03-27
EP0759301A2 (de) 1997-02-26
AU706952B2 (en) 1999-07-01
TW415844B (en) 2000-12-21
KR100420260B1 (ko) 2004-06-04
JPH09136838A (ja) 1997-05-27

Similar Documents

Publication Publication Date Title
DE69613058D1 (de) Vorbeugung und Behandlung von topischen viralen Infektionen mit Perfluoropolyäthern oder deren Zusammensetzungen
FI952302L (fi) Pyran-2-onit ja 5,6-dihydropyranonit, jotka ovat käyttökelpoisia HIV:n ja muiden retrovirusten hoidossa
DE69101922D1 (de) Verwendung von pyrimidin-3-oxydderivaten zur verhütung von haarausfall und deren anwendung in topischen zusammensetzungen.
BG98902A (bg) Имидазолови производни и тяхната употреба като инхибитори на цитокин
DK0445255T4 (da) Anvendelse af hyaluronsyre i kombination med ascorbinsyre, antitumormidler og/eller NSAID's til behandling af cancer
ATE183638T1 (de) Festes produkt zur behandlung von xerostomie
ES8606289A1 (es) Un procedimiento para la preparacion de piridazinaminas.
DK0574457T3 (da) Antiviral nucleosidkombination
FI955911A7 (fi) Pyratsolopyrimidinonit impotenssin hoidossa
ES2191292T3 (es) Compuestos antivirales poliaromaticos.
DE69420967D1 (de) Lösung zur verwendung gegen den pilzbefall von nägeln
EP1001782A4 (de) 5,6-HETEROARYL-DIPYRIDO (2-3-b:3',2'-f) AZEPINE UND DEREN VERWENDUNG ZUR PROPHYLAXE UND BEHANDLUNG VON HIV-INFEKTIONEN
TR199901754T2 (xx) Helicobacter pylori enfeksiyonlar�n�n ve bunlarla ba�lant�l� gastro-duodenal rahats�zl�klar�n tedavisinde
DE69131200D1 (en) Herpes simplex virus vp16 impfstoffe
DE69300806D1 (de) Lackhilfsmittel und wasserverdünnbare Farbzusammensetzung.
EP0296573A3 (en) Novel nucleosides, their preparation and pharmaceutical novel nucleosides, their preparation and pharmaceutical compositions compositions
ES8800160A1 (es) Procedimiento de obtencion de acidos quinolincarboxilicos con propiedades antibacteriales.
TR26917A (tr) Optik düzenekler ve özel olarak etalonlarda kullanilmaya yönelik kaplamalar.
OA09917A (en) Compounds for use in treating HIV infection
IE873323L (en) Treatment of psoriasis
AU1146083A (en) 2,3-diaryl-5-halo thiophenes
FI944933A7 (fi) 7-disubstitoitu metyyli-4-okso-3H,5H-pyrrolo(3,2-d) pyrimidiini ja sit ä sisältäviä farmaseuttisia käyttöjä ja koostumuksia
ES2106183T3 (es) Suero antiveneno.
TR199802270A2 (xx) S�lfonamid-ikame etmi� anelize 5-halka-bile�ikleri.
DE68914454D1 (de) Pharmazeutische zusammensetzungen und deren verwendung in der behandlung von entzündungen.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties